Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by HuntNGatheron Jan 12, 2015 3:14pm
69 Views
Post# 23311380

RE:RE:After Market......

RE:RE:After Market......It is nice to get one forecast in the win column for a change.   Lord knows I have predicted it poorly in the past..   Let's hope that TR enjoys the quick upward flick that TRIL started after hours today when the bell rings tomorrow.   Until then, sleep well. Don't count your chickens until the eggs hatch.  Myself, I am getting a fair amount of pleasure out of just counting the eggs for now .
Bullboard Posts